Meditation Mobile App Developed for Patients With and Survivors of Cancer: Feasibility Randomized Controlled Trial.

ABSTRACT:

Background

To address the unmet need for a commercial cancer-specific meditation app, we leveraged a long-standing partnership with a consumer-based app (ie, Calm) to develop the first commercial meditation app prototype adapted specifically for the needs of patients with cancer. Input was obtained at both the individual user and clinic levels (ie, patients with and survivors of cancer and health care providers).

Objective

This study aimed to determine the feasibility of a cancer-specific meditation app prototype.

Methods

Patients with and survivors of cancer who were recruited and enrolled in the feasibility randomized controlled trial were asked to use the prototype app daily (≥70 minutes per week) for 4 weeks. Participants completed web-based weekly questionnaires

SUBMITTER: Huberty J 

PROVIDER: S-EPMC9730204 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature